Intra-Cellular Therapies (ITCI) PT Lowered to $68 at BofA Securities

July 11, 2022 9:39 AM EDT Send to a Friend

BofA Securities analyst Jason Gerberry ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Intra-Cellular Therapies (ITCI) PT Lowered to $68 at BofA Securities

Member Login

Free News Feed